Sorrento Therapeutics, Inc. announced Dean Ferrigno, the Vice President of Finance and Chief Accounting Officer of Sorrento Therapeutics, Inc., notified the company of his intention to resign from his roles with the Company, effective March 23, 2018. Effective March 19, 2018, the Company appointed Jiong Shao as the Company's Executive Vice President and Chief Financial Officer. Upon commencement of his appointment, Mr. Shao assumed the duties of the company's principal financial officer and principal accounting officer until such time as his successor is appointed, or until his earlier resignation or removal.

Prior to joining the company, Jiong Shao was Managing Director, Head of U.S. Office, at CEC Capital.